PeptideStack
5.2kquestions
20kanswers
220users

Is LDL-C worth drawing at baseline before starting cagrilintide?

Asked 14 Oct 2024Modified 19 months agoViewed 19k times
This question was marked as a duplicate of Is ALT worth drawing at baseline before starting mazdutide?Closed 21 Nov 2024. It remains here because the answers below are specific to how it was asked.
38

For reference: LDL-C · cagrilintide.

I would like to set this up properly once, rather than adjust it repeatedly.

My budget is real but not tight, and my tolerance for uncertainty is low.

How would you structure this, and what thresholds would you set in advance?

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
a1c
a1c

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it…

122 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
amylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questions
shareeditfollowflag
BU
askedbufferline4230k13814 Oct 2024
Same laboratory as last time? Between-laboratory differences are larger than most of the changes people chase. – dermot_kiely 7 months ago
Can you say how far out of range rather than that it was flagged? The flag is a threshold, not a finding. – Dr_Priya_Raghunathan 5 months ago
add a comment

5 Answers

Accepted answer first, then by votes
54

Accepted answer

The honest position is that most people order too many analytes and too few time points, when the reverse would be more informative.

Delta checks — comparing against your own previous value — are far more sensitive than comparing against a population interval, which is the argument for keeping a series rather than a snapshot.

Headline results, principal programmes

TrialAgentnDurationPrimary result
STEP 1Semaglutide 2.4 mg1,96168 wk−14.9 % vs −2.4 % weight
STEP 2Semaglutide 2.4 mg, T2DM1,21068 wk−9.6 % vs −3.4 % weight
SURMOUNT-1Tirzepatide 5/10/15 mg2,53972 wk−15 / −19 / −21 % weight
SURMOUNT-4Tirzepatide, withdrawal67088 wkContinued loss vs substantial regain
SELECTSemaglutide 2.4 mg17,604~40 moMACE HR 0.80 (0.72–0.90)
FLOWSemaglutide 1.0 mg, CKD3,533~3.4 yrRenal composite reduced; stopped early
SURMOUNT-OSATirzepatide, OSA46952 wkAHI reduced with and without PAP

A twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

Biological variation data are published per analyte and are the basis for the reference change value — the difference between two results that is larger than noise.

Nothing here is medical advice. If something is out of range and you do not know why, that is a consultation rather than a research project.

Decide the action for each result before you order the test.

shareimprove this answerflag
DB
answered · acceptedDr_Ingrid_Baumgartner73k5828 Nov 2024
Adding a vote because this deserves more of them. – Dr_Elias_Weiss 4 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
49

Answering this needs to distinguish screening from monitoring. A screening panel looks for the unexpected; a monitoring panel tracks something you already have a reason to watch.

Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

On the detail: haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

The caveat is that a panel is not a diagnosis and interpreting one is a clinician's job, particularly when several values move together.

Same laboratory, same time, same fasting state, or the comparison is not a comparison.

shareimprove this answerflag
LQ
answeredlipid_panel_q36k12717 Nov 2024
26

Before reacting to any single value, check whether it is outside the interval by an amount larger than the assay's own variation.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

Put another way, a sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

External quality assurance schemes document between-laboratory differences on common analytes that routinely exceed the size of clinically interesting changes.

Keep the full report, not the number. You will need the units and the interval later.

shareimprove this answerflag
LQ
answeredlipid_panel_q36k1279 Dec 2024
4Same laboratory every time is advice I ignored for a year, and the series was useless because of it. – lyoph_cake 9 months ago
3Same experience here, different supplier. – rota_site 8 months ago
add a comment
20

Answer first: decide what you would do differently for each possible result before you order the panel. Anything that fails that test is a number you will worry about and not act on.

Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.

Baseline first, then a repeat under identical conditions. Everything else is secondary.

shareimprove this answerflag
HP
answeredh_pergande71k15821 Dec 2024
5Minor: haemolysis inflates potassium enough to cause a fright over what is a handling artefact. – label_claim 4 months ago
add a comment
14

Standardise the conditions — same time of day, same fasting state, same laboratory — or you are measuring the conditions rather than yourself.

Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.

One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.

shareimprove this answerflag
FB
answeredfresh_bac9.7k161 Jan 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.